ASKA Pharmaceutical Holdings Co., Ltd.(JP:4886)
Â¥2,123.00+39.00 (+4.79%)
JP:4886
ASKA Pharmaceutical Holdings Co., Ltd. financials statements
Â¥2,123.00
At close:+39.00 (+4.79%)
Want to see JP:4886 full AI Analyst Report?
ASKA Pharmaceutical Holdings Co., Ltd. (4886) Ratios
0 Followers
ASKA Pharmaceutical Holdings Co., Ltd. Ratios
JP:4886's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:4886's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.76 | 2.54 | 2.34 | 3.05 | 3.10 |
| Quick Ratio | 1.45 | 1.39 | 1.49 | 2.04 | 2.15 |
| Cash Ratio | 0.45 | 0.46 | 0.57 | 0.82 | 0.76 |
| Solvency Ratio | 0.23 | 0.22 | 0.35 | 0.23 | 0.21 |
| Operating Cash Flow Ratio | 0.28 | 0.11 | 0.06 | 0.19 | 0.18 |
| Short-Term Operating Cash Flow Coverage | 1.93 | 0.56 | 0.30 | 0.97 | 1.65 |
| Net Current Asset Value | ¥ 25.86B | ¥ 23.99B | ¥ 27.33B | ¥ 21.15B | ¥ 15.15B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.11 | 0.10 | 0.14 | 0.17 |
| Debt-to-Equity Ratio | 0.16 | 0.17 | 0.15 | 0.23 | 0.29 |
| Debt-to-Capital Ratio | 0.14 | 0.14 | 0.13 | 0.19 | 0.22 |
| Long-Term Debt-to-Capital Ratio | 0.10 | 0.09 | 0.07 | 0.14 | 0.20 |
| Financial Leverage Ratio | 1.60 | 1.58 | 1.47 | 1.60 | 1.70 |
| Debt Service Coverage Ratio | 2.12 | 1.44 | 2.04 | 2.13 | 4.06 |
| Interest Coverage Ratio | 26.28 | 104.57 | 162.50 | 102.16 | 85.63 |
| Debt to Market Cap | 0.17 | 0.17 | 0.16 | 0.38 | 0.39 |
| Interest Debt Per Share | 410.65 | 386.39 | 336.42 | 448.78 | 497.07 |
| Net Debt to EBITDA | 0.15 | 0.04 | -0.34 | -0.22 | 0.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.01% | 48.86% | 48.80% | 47.28% | 46.55% |
| EBIT Margin | 8.20% | 8.31% | 15.76% | 8.94% | 10.99% |
| EBITDA Margin | 12.30% | 11.82% | 20.00% | 14.11% | 16.08% |
| Operating Profit Margin | 8.20% | 8.31% | 10.34% | 8.45% | 8.47% |
| Pretax Profit Margin | 9.83% | 9.65% | 15.69% | 8.86% | 10.89% |
| Net Profit Margin | 7.63% | 7.95% | 12.01% | 7.01% | 7.58% |
| Continuous Operations Profit Margin | 7.91% | 7.95% | 12.01% | 7.01% | 7.58% |
| Net Income Per EBT | 77.60% | 82.38% | 76.51% | 79.11% | 69.61% |
| EBT Per EBIT | 119.83% | 116.11% | 151.72% | 104.87% | 128.53% |
| Return on Assets (ROA) | 4.84% | 4.94% | 8.31% | 4.86% | 5.15% |
| Return on Equity (ROE) | 7.75% | 7.81% | 12.18% | 7.77% | 8.77% |
| Return on Capital Employed (ROCE) | 6.50% | 6.64% | 9.73% | 7.35% | 7.13% |
| Return on Invested Capital (ROIC) | 5.05% | 5.18% | 6.93% | 5.54% | 4.84% |
| Return on Tangible Assets | 5.26% | 5.30% | 8.59% | 5.13% | 5.56% |
| Earnings Yield | 8.10% | 7.81% | 12.34% | 12.62% | 11.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.46 | 4.25 | 4.03 | 3.97 | 3.91 |
| Payables Turnover | 4.89 | 3.59 | 4.37 | 11.23 | 9.70 |
| Inventory Turnover | 1.27 | 1.25 | 1.58 | 1.80 | 2.01 |
| Fixed Asset Turnover | 3.70 | 3.43 | 5.58 | 5.60 | 5.18 |
| Asset Turnover | 0.63 | 0.62 | 0.69 | 0.69 | 0.68 |
| Working Capital Turnover Ratio | 1.91 | 1.90 | 1.84 | 1.74 | 2.00 |
| Cash Conversion Cycle | 295.29 | 277.11 | 238.48 | 261.89 | 237.45 |
| Days of Sales Outstanding | 81.88 | 85.87 | 90.48 | 91.86 | 93.38 |
| Days of Inventory Outstanding | 288.01 | 293.01 | 231.42 | 202.53 | 181.69 |
| Days of Payables Outstanding | 74.59 | 101.77 | 83.43 | 32.50 | 37.62 |
| Operating Cycle | 369.88 | 378.88 | 321.91 | 294.39 | 275.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 222.06 | 87.66 | 52.48 | 118.67 | 100.18 |
| Free Cash Flow Per Share | 132.26 | -16.76 | 1.17 | 92.25 | 16.39 |
| Dividend Paid and CapEx Coverage Ratio | 1.51 | 0.59 | 0.66 | 2.80 | 1.02 |
| Capital Expenditure Coverage Ratio | 2.47 | 0.84 | 1.02 | 4.49 | 1.20 |
| Operating Cash Flow Coverage Ratio | 0.55 | 0.23 | 0.16 | 0.27 | 0.20 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.04 | 0.02 | 0.06 | 0.05 |
| Free Cash Flow Yield | 5.60% | -0.73% | 0.05% | 7.76% | 1.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.35 | 12.80 | 8.11 | 7.92 | 8.35 |
| Price-to-Sales (P/S) Ratio | 0.94 | 1.02 | 0.97 | 0.56 | 0.63 |
| Price-to-Book (P/B) Ratio | 0.96 | 1.00 | 0.99 | 0.62 | 0.73 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.84 | -137.50 | 1853.21 | 12.89 | 77.06 |
| Price-to-Operating Cash Flow Ratio | 10.63 | 26.28 | 41.15 | 10.02 | 12.61 |
| Price-to-Earnings Growth (PEG) Ratio | 1.99 | -0.39 | 0.10 | -10.51 | 0.14 |
| Enterprise Value Multiple | 7.80 | 8.66 | 4.53 | 3.71 | 4.15 |
| Enterprise Value | 68.29B | 65.61B | 56.90B | 31.69B | 37.77B |
| EV to EBITDA | 7.80 | 8.66 | 4.53 | 3.71 | 4.15 |
| EV to Sales | 0.96 | 1.02 | 0.91 | 0.52 | 0.67 |
| EV to Free Cash Flow | 18.19 | -138.13 | 1724.34 | 12.17 | 81.24 |
| EV to Operating Cash Flow | 10.84 | 26.40 | 38.29 | 9.46 | 13.29 |
| Tangible Book Value Per Share | 2381.06 | 2194.38 | 2085.69 | 1772.94 | 1505.39 |
| Shareholders’ Equity Per Share | 2465.93 | 2303.95 | 2187.33 | 1931.05 | 1723.33 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.18 | 0.23 | 0.21 | 0.30 |
| Revenue Per Share | 2505.88 | 2262.64 | 2219.58 | 2141.05 | 1995.31 |
| Net Income Per Share | 191.13 | 179.95 | 266.49 | 150.08 | 151.22 |
| Tax Burden | 0.78 | 0.82 | 0.77 | 0.79 | 0.70 |
| Interest Burden | 1.20 | 1.16 | 1.00 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.10 | 0.11 | 0.08 | 0.07 | 0.06 |
| SG&A to Revenue | 0.30 | 0.30 | 0.21 | 0.22 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.16 | 0.49 | 0.20 | 0.63 | 0.46 |
Currency in JPY
